Search

everythinglearnresearchcommunity

for

Search:↓

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

Transferrin receptor 1 is essential for normal function in the intestines, pancreas, and skin.

Sintilimab treatment caused hair loss but led to complete tumor remission.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Finasteride increases CD8+ T cells in BPH tissues.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Moderate immune responses help hair growth, while excessive responses slow it down.

Tanshinone compounds can help prevent hair loss caused by testosterone.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.